Supplement shows promise for aromatase inhibitor joint pain
NCT ID NCT07199556
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 40 times
Summary
This study tested a food supplement (Tenflex) containing collagen and chondroitin sulfate to see if it could reduce joint and muscle pain in 30 women with hormone-positive breast cancer. All participants were on aromatase inhibitor therapy and had pain for less than 6 months. The study measured pain changes over 12 weeks using a standard pain questionnaire.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínic Barcelona
Barcelona, 08036, Spain
Conditions
Explore the condition pages connected to this study.